Open AccessIs the second jab of an anti-SARS-CoV-2 vaccine reasonable after guillain–Barre syndrome following the first dose?
Author(s) -
Josef Finsterer
Publication year - 2022
Publication title -
indian journal of public health/indian journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.381
H-Index - 26
eISSN - 2229-7693
pISSN - 0019-557X
DOI - 10.4103/ijph.ijph_106_22
Subject(s) - guillain barre syndrome , medicine , covid-19 , betacoronavirus , virology , pediatrics , infectious disease (medical specialty) , disease , outbreak